Nanoscale radiotherapy with hafnium oxide nanoparticles

Future Oncology

Volumn 8, Issue 9, 2012, Pages 1167-1181

  Maggiorella, Laurence ^a   Barouch, Gilles ^b   Devaux, Corinne ^a   Pottier, Agnès ^a   Deutsch, Eric ^c   Bourhis, Jean ^c   Borghi, Elsa ^a   Levy, Laurent ^a  

^a NANOBIOTIX   (France)

^b IRFM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

cancer; hafnium oxide; nanoparticles; nanotechnology; NBTXR3; radiotherapy; therapy

Indexed keywords

ANTINEOPLASTIC AGENT; COBALT 60; HAFNIUM OXIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELLULAR DISTRIBUTION; COLORECTAL TUMOR; CONTROLLED STUDY; CYTOPLASM; DISPERSION; EWING SARCOMA; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; MONTE CARLO METHOD; MOUSE; NONHUMAN; PHOTON; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SINGLE DRUG DOSE; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; COMPUTER SIMULATION; ENDOSOMES; FEMALE; HAFNIUM; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; MONTE CARLO METHOD; NANOPARTICLES; NEOPLASMS; OXIDES; RADIATION-SENSITIZING AGENTS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84867095663     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.96     Document Type: Article

References (33)

1. Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat. Rev. Cancer 4, 737-747 (2006).
2. Palma DA, Verbakel WF, Otto K, Senan S. New developments in arc radiation therapy: a review. Cancer Treat. Rev. 36, 393-399 (2010).
3. Martin A, Gaya A. Stereotactic body radiotherapy: a review. Clin. Oncol. 22, 157-172 (2010).
4. Matuszak MM, Di Y, Grills I, Martinez A. Clinical applications of volumetric modulated arc therapy. Int. J. Radiat. Oncol. Biol. Phys. 77, 608-616 (2010).
5. Amaldi U, Bonomi R, Braccini S et al. Accelerators for hadrontherapy: from Lawrence cyclotrons to linacs. Nucl. Instrum. Methods Phys. Res. A 620, 563-577 (2010).
6. Giro C, Berger B, Bölke E et al. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes. Radiother. Oncol. 90, 166-171 (2009).
7. Schweitzer AD, Revskaya E, Chu P et al. Melanin-covered nanoparticles for protection of bone marrow during radiation therapy of cancer. Int. J. Radiat. Oncol. Biol. Phys. 78, 1494-1502 (2010).
8. Cho SH. Estimation of tumor dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys. Med. Biol. 50, N163-N173 (2005).
9. Roeske JC, Nunez L, Hoggarth M, Labay E, Weichselbaum RR. Characterization of the theorectical radiation dose enhancement from nanoparticles. Technol. Cancer Res. Treat. 6, 395-401 (2007).
10. Salvat F, Fernandez-Varea JM, Sempau J. PENELOPE-A Code System for Monte Carlo Simulation of Electron and Photon Transport: Workshop Proceedings, Issy-les-Moulineaux, France, 7-10 July 2003. Nuclear Energy Agency, Paris, France (2003).
11. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315-2319 (2006).
12. Langdon SP, Hendriks HR, Braakhuis BJM et al. Preclinical Phase II studies in human tumor xenografts: a European multicenter follow-up study. Ann. Oncol. 5, 412-422 (1994).
13. Jones BL, Krishnan S, Cho SH. Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations. Med. Phys. 37, 3809-3816 (2010).
14. Herold DM, Das IJ, Stobbe CC, Lyer RV, Chapman JD. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int. J. Radiat. Biol. 76, 1357-1364 (2000).
15. Kong T, Zeng J, Wang X et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small 4, 1537-1543 (2008).
16. Liu CJ, Wang CH, Chen ST et al. Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys. Med. Biol. 55, 931-945 (2009).
17. Chithrani BD, Jelveh S, Jalali F et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat. Res. 173, 719-728 (2010).
18. Jain SJ, Coulter JA, Hounsell AR et al. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int. J. Radiat. Oncol. Biol. Phys. 79, 531-539 (2011).
19. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49, N309-N315 (2004).
20. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new x-ray contrast agent. Br. J. Radiol. 79, 248-253 (2006).
21. Von Maltzahn G, Park JH, Agrawal A et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 69, 3892-3900 (2009).
22. Chen YS, Hung YC, Liau I, Huang GS. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res. Lett. 4, 858-864 (2009).
23. Sadauskas E, Danscher G, Toltenberg M, Vogel U, Larsen A, Wallin H. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5, 162-169 (2009).
24. Cho WS, Cho M, Jeong J et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 236, 16-24 (2009).
25. Nel AE, Mädler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8, 543-557 (2009).
26. Jolivet JP, Cassaignon S, Chanéac C, Chiche D, Durupthy O, Portehault D. Design of metal oxide nanoparticles: control of size, shape, crystalline structure and functionalization by aqueous chemistry. C. R. Chim. 13, 40-51 (2010).
27. Auffan M, Rose J, Wiesner MR, Bottero JY. Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro. Environ. Pollut. 157, 1127-1133 (2009).
28. Auffan M, Rose J, Orsiere T et al. CeO2 nanoparticles induce DNA damage towards human dermal fibroblasts in vitro. Nanotoxicology 3, 161-171 (2009).
29. Garcia JC, Lino AT, Scolfaro LM et al. First principles studies of relativistic and spin?orbit effects on the HfO2 band structures. Phys. Stat. Sol. 1(Suppl. 1), S236-S240 (2004).
30. Kosmulski M. Attempt to determine pristine points of zero charge of Nb2O5, Ta2O5, and HfO2. Langmuir 13, 6315-6320 (1997).
31. Wilhem C, Gazeau F. Universal cell labeling with ionic magnetic nanoparticles. Biomaterials 29, 3161-3174 (2008).
32. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662-668 (2006).
33. Chithrani BD, Chan WC. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 7, 1542-1550 (2007).